Accès ouvert · CC BY

Anti-inflammatory effects of metformin in gestational diabetes: Systematic review and meta-analysis of randomized trials and preclinical animal pregnancy models study protocol

Article scientifique 2026 Sciences de la santé Anglais

Résumé

BACKGROUND: Gestational diabetes mellitus (GDM) is a significant complication that can occur during pregnancy. It is characterized by glucose intolerance that first arises during pregnancy and is associated with insulin resistance, which is linked to elevated inflammatory markers. Metformin has emerged as a promising treatment option for GDM, with growing evidence supporting its anti-inflammatory effects. These effects are thought to be mediated by activation of AMP-activated protein kinase (AMPK) and inhibition of NF-κB signaling. This systematic review aims to assess the anti-inflammatory effects of metformin in GDM, considering both clinical and preclinical studies. METHODS: A systematic review of all randomized controlled trials and controlled in vivo experiments for animals published until 2026 will be carried out. A comprehensive search of all published articles indexed in PubMed/MEDLINE, the Cochrane Library, Scopus, CINAHL (EBSCOhost), Embase, and Web of Science will be performed. Studies will be screened for eligibility by title, abstract, and full text in duplicate by two independent reviewers. For data where meta-analysis is not possible, a narrative analysis will be conducted using themes derived from the data. For data that allow meta-analysis, a random-effects meta-analysis will be conducted. This systematic review will be reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA). DISCUSSION: The study will utilize meta-analysis to establish the anti-inflammatory effects of metformin in GDM, potentially influencing clinical practice and guidelines. Additionally, validating metformin's anti-inflammatory effects has important implications beyond immediate management of GDM, extending to long-term adverse outcomes for both the mother and the offspring. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD420261337881.

Citer ce document

Ogra, I. O., Oyibo, A., Kernyuy, F. B., Adereti, A. O., Feranmi, B. O., Afolabi, K. O., Musa, G. C., Ojiakor, V. O., Mahe, U.-F. A., Ojo, O. O., Werfalli, M., Ohiomokhare, S., Sossou, K., Okoh, O. S., & Musa, E. (2026). Anti-inflammatory effects of metformin in gestational diabetes: Systematic review and meta-analysis of randomized trials and preclinical animal pregnancy models study protocol. PLoS ONE. https://doi.org/10.1371/journal.pone.0361047

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 16/11/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations (hors robots) : 3

Téléchargements (hors robots) : 0

Méthode de comptage